In May 2024, French pharmaceutical giant Sanofi announced a three-way collaboration with Formation Bio and OpenAI to develop AI software for drug research. William Tsai, Sanofi's Head of Public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback